Literature DB >> 9034402

Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study.

I B Borecki1, M A Province, E H Ludwig, R C Ellison, A R Folsom, G Heiss, J M Lalouel, M Higgins, D C Rao.   

Abstract

PURPOSE: In studies conducted in several different populations, the M235T substitution in the angiotensinogen (AGT) locus has been associated with hypertension.
METHODS: A case-control study was initiated in an attempt to replicate this finding. Persons with hypertension, age- and sex-matched normotensive controls, and randomly sampled individuals were probands from the Family Heart Study of the National Heart, Lung, and Blood Institute. Subjects were recruited from the Atherosclerosis Risk in Communities study (ARIC) in North Carolina and Minneapolis, MN, and from the Framingham Heart Study in Massachusetts. Genotypes were determined for the M235T substitution in the AGT locus and for the insertion/deletion polymorphism in the angiotensin-converting enzyme (ACE) locus. Simple association tests as well as logistic regression analyses were performed.
RESULTS: The association of AGT-T235 with hypertension was replicated in the Framingham sample (odds ratio, 1.60; 95% confidence interval, 1.11-2.30), but not in the ARIC white or black subjects. However, logistic regression analysis suggested a significant association of AGT with hypertension in both the ARIC white and Framingham samples when the effects of body mass index, triglycerides, and the presence of significant coronary heart disease were controlled. These analyses further suggested that, in the ARIC data, the relationship with the AGT locus is stronger in women than men and that there may be interaction (epistasis) between homozygotes for T235 and ACE-DD in the Framingham data. While the small sample size precluded logistic regression analysis, the frequency of the T235 allele in the black random sample was much higher than in the comparable white sample.
CONCLUSIONS: These results are compatible with the presence of a genetic risk factor for hypertension in or near the angiotensinogen locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034402     DOI: 10.1016/s1047-2797(97)00155-5

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  10 in total

Review 1.  Searching for the mountains of the moon: genome scans for atherosclerosis.

Authors:  Michael A Province
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

2.  Race, genes and preterm delivery.

Authors:  Kevin Fiscella
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 3.  Angiotensinogen variants and human hypertension.

Authors:  X Jeunemaitre; A P Gimenez-Roqueplo; J Célérier; P Corvol
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

4.  Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system.

Authors:  Laura P Svetkey; Emily L Harris; Eden Martin; William M Vollmer; Gayle T Meltesen; Vincent Ricchiuti; Gordon Williams; Lawrence J Appel; George A Bray; Thomas J Moore; Michelle P Winn; Paul R Conlin
Journal:  Am J Hypertens       Date:  2010-11-18       Impact factor: 2.689

5.  Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure.

Authors:  X Zhu; N Bouzekri; L Southam; R S Cooper; A Adeyemo; C A McKenzie; A Luke; G Chen; R C Elston; R Ward
Journal:  Am J Hum Genet       Date:  2001-03-27       Impact factor: 11.025

6.  Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 in African American and Caucasian women.

Authors:  Laura D Jenkins; Robert W Powers; Mary Cooper; Marcia J Gallaher; Nina Markovic; Robert Ferrell; Roberta B Ness; James M Roberts
Journal:  Reprod Sci       Date:  2008-06-18       Impact factor: 3.060

7.  Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure.

Authors:  Marcin Zakrzewski-Jakubiak; Simon de Denus; Marie-Pierre Dubé; François Bélanger; Michel White; Jacques Turgeon
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

8.  Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data.

Authors:  Adrian Mondry; Marie Loh; Pengbo Liu; Ai-Ling Zhu; Mato Nagel
Journal:  BMC Nephrol       Date:  2005-01-11       Impact factor: 2.388

9.  Intercellular adhesion molecule-1 K469E and angiotensinogen T207M polymorphisms in coronary slow flow.

Authors:  Emine Gazi; Ahmet Barutcu; Burak Altun; Ahmet Temiz; Adem Bekler; Mine Urfali; Fatma Silan; Yucel Colkesen; Ozturk Ozdemir
Journal:  Med Princ Pract       Date:  2014-06-14       Impact factor: 1.927

10.  No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension.

Authors:  Adam V Benjafield; William Y S Wang; Brian J Morris
Journal:  Am J Hypertens       Date:  2004-07       Impact factor: 2.689

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.